Profil
David J.
Maloney is the founder of Veralox Therapeutics, Inc. since 2017, holding the title of Chief Scientific Officer.
Formerly, a Vice President & Head-Translational Medicine at Rebus Holdings, Inc. in 2017.
Education includes a doctorate from the University of Virginia and an undergraduate degree from the University of Vermont.
Postes actifs de David J. Maloney
| Sociétés | Poste | Début |
|---|---|---|
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Fondateur | 01/01/2017 |
Anciens postes connus de David J. Maloney
| Sociétés | Poste | Fin |
|---|---|---|
| INSPYR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2017 |
Formation de David J. Maloney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Rebus Holdings, Inc.
Rebus Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of novel targeted precision therapeutics | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company | Health Technology |
















